Soc. Generale Call 230 MRK 19.12..../ DE000SU9GP27 /
2024-08-26 2:46:00 PM | Chg.+0.010 | Bid3:11:55 PM | Ask3:11:55 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.620EUR | +1.64% | 0.630 Bid Size: 25,000 |
0.650 Ask Size: 25,000 |
MERCK KGAA O.N. | 230.00 EUR | 2025-12-19 | Call |
GlobeNewswire
06-03
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA